GlassScriptPhysician profile
Sarika Arora
NPI 1184909335
$7,753.74
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2021: $186 · 2022: $12.50 · 2023: $98.87 · 2024: $7,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $1,358 · Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $1,357.56 |
| Food and Beverage | $320.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,943.56 | 2022-2024 | |
| Asensus Surgical, INC. | $185.75 | 2021 | |
| Baxter Healthcare | $148.49 | 2024 | Tisseel |
| Hologic Sales and Service, LLC | $118.18 | 2019 | |
| Coopersurgical, INC. | $99.00 | 2019 | |
| Gynesonics, INC. | $98.87 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Merck Sharp & Dohme LLC | $35.28 | 2019 | |
| Ferring Pharmaceuticals INC. | $30.39 | 2019 | |
| Glaxosmithkline, LLC. | $25.67 | 2019 | |
| Gilead Sciences, INC. | $24.62 | 2019 | |
| Lilly USA, LLC | $18.97 | 2019 | |
| Sobi, INC | $13.51 | 2019 | |
| Astellas Pharma US INC | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarika Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.